Organigram Holdings Inc. (TSE:OGI – Get Free Report) insider Katrina May Mcfadden sold 11,655 shares of the stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total transaction of C$29,020.95. Following the completion of the sale, the insider directly owned 30,326 shares of the company’s stock, valued at approximately C$75,511.74. This trade represents a 27.76% decrease in their position.
Katrina May Mcfadden also recently made the following trade(s):
- On Tuesday, October 21st, Katrina May Mcfadden sold 5,135 shares of Organigram stock. The shares were sold at an average price of C$2.49, for a total transaction of C$12,786.15.
- On Thursday, October 30th, Katrina May Mcfadden sold 8,278 shares of Organigram stock. The shares were sold at an average price of C$2.25, for a total value of C$18,625.50.
Organigram Trading Down 2.3%
OGI stock traded down C$0.05 during midday trading on Friday, hitting C$2.11. 117,363 shares of the company’s stock were exchanged, compared to its average volume of 176,953. Organigram Holdings Inc. has a 1-year low of C$1.22 and a 1-year high of C$2.89. The company has a current ratio of 3.36, a quick ratio of 2.62 and a debt-to-equity ratio of 3.07. The stock has a market capitalization of C$282.50 million, a PE ratio of 175.83, a P/E/G ratio of 0.42 and a beta of 2.16. The business has a 50-day simple moving average of C$2.43 and a two-hundred day simple moving average of C$2.11.
Organigram Company Profile
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Featured Articles
- Five stocks we like better than Organigram
- What is the Nikkei 225 index?
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- How Technical Indicators Can Help You Find Oversold Stocks
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
- How to Invest in Blue Chip Stocks
- MarketBeat Week in Review – 11/10 – 11/14
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.
